488 related articles for article (PubMed ID: 9405164)
1. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of the STAT pathway by angiotensin II via angiotensin type 1 and type 2 receptors in cultured human fetal mesangial cells.
Seebach FA; Welte T; Fu XY; Block LH; Kashgarian M
Exp Mol Pathol; 2001 Jun; 70(3):265-73. PubMed ID: 11418005
[TBL] [Abstract][Full Text] [Related]
5. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
McWhinney CD; Hunt RA; Conrad KM; Dostal DE; Baker KM
J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
[TBL] [Abstract][Full Text] [Related]
6. Signal transducers and activators of transcription 3 mediates up-regulation of angiotensin II-induced tissue inhibitor of metalloproteinase-1 expression in cultured human senescent fibroblasts.
Wang XD; Chen XM; Wang JZ; Hong Q; Feng Z; Fu B; Zhou F; Wang FY; Fan DM
Chin Med J (Engl); 2006 Jul; 119(13):1094-102. PubMed ID: 16834928
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling.
Tsai CT; Lai LP; Kuo KT; Hwang JJ; Hsieh CS; Hsu KL; Tseng CD; Tseng YZ; Chiang FT; Lin JL
Circulation; 2008 Jan; 117(3):344-55. PubMed ID: 18172037
[TBL] [Abstract][Full Text] [Related]
8. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.
Booz GW; Baker KM
Cardiovasc Res; 1995 Oct; 30(4):537-43. PubMed ID: 8575002
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
10. Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.
Hernández-Vargas P; López-Franco O; Sanjuán G; Rupérez M; Ortiz-Muñoz G; Suzuki Y; Aguado-Roncero P; Pérez-Tejerizo G; Blanco J; Egido J; Ruiz-Ortega M; Gómez-Guerrero C
J Am Soc Nephrol; 2005 Jun; 16(6):1673-83. PubMed ID: 15829701
[TBL] [Abstract][Full Text] [Related]
11. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.
Marrero MB; Schieffer B; Paxton WG; Heerdt L; Berk BC; Delafontaine P; Bernstein KE
Nature; 1995 May; 375(6528):247-50. PubMed ID: 7746328
[TBL] [Abstract][Full Text] [Related]
12. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
Rosendorff C
Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
14. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.
Saito Y; Berk BC
J Mol Cell Cardiol; 2001 Jan; 33(1):3-7. PubMed ID: 11133218
[TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
16. The angiotensin II type 1 receptor and receptor-associated proteins.
Guo DF; Sun YL; Hamet P; Inagami T
Cell Res; 2001 Sep; 11(3):165-80. PubMed ID: 11642401
[TBL] [Abstract][Full Text] [Related]
17. JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases.
Grote K; Luchtefeld M; Schieffer B
Vascul Pharmacol; 2005 Nov; 43(5):357-63. PubMed ID: 16271517
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases.
Inagami T; Eguchi S; Numaguchi K; Motley ED; Tang H; Matsumoto T; Yamakawa T
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S57-61. PubMed ID: 9892141
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
Kim S; Iwao H
Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II-stimulated collagen gel contraction by heart fibroblasts: role of the AT1 receptor and tyrosine kinase activity.
Watson S; Burnside T; Carver W
J Cell Physiol; 1998 Nov; 177(2):224-31. PubMed ID: 9766519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]